J&J to Pay $140M After High Court Refuses Appeal

Drug Industry Daily
A A
The U.S. Supreme Court has refused to hear Johnson & Johnson’s appeal of an unfavorable ruling in a negligent labeling case, a decision that will cost the company $140 million.

To View This Article:

Login

Subscribe To Drug Industry Daily